This FASEB SRC is the next iteration of a liver-focused meeting that has been held biennially since 1988. It is recognized as the premier small conference covering all aspects of basic research involving the liver. The main goals of the conference are to i) present and integrate research advances in disparate areas of liver biology in order to foster new national and international collaborative projects, ii) encourage junior and early stage investigators, women and minority scientists to pursue liver research to ensure that the study of hepatic disease and biology remains vigorous and iii) accelerate translation of fundamental advances into novel clinical treatments through the interactions of basic and clinical researchers. These goals will be achieved through specific programmatic strategies.
The program is divided into seven major sessions and includes presentations from 41 invited speakers. These sessions will also include 15 short 'late-breaking' talks chosen to represent the most significant and timely research advances in liver research. Preference will be given to junior, minority and women investigators. The program provides poster sessions and two scheduled lunch time “meet-the-expert” sessions for one-on-one dialogue, as well as several additional opportunities for informal, yet intimate scientific exchange among speakers and attendees.
There is also a newly scheduled career development session for junior researchers, in which two senior and one mid-stage colleague will share experiences and respond to questions. While the conference will keep the tradition of covering a wide range of basic science and translational topics - including liver organogenesis, regulation of hepatobiliary gene expression in health and disease, liver regeneration, liver injury and fibrosis, liver stem cells and regenerative medicine - there will be particular focus on hepatic metabolism and fatty liver as well as liver cancer due to their growing relevance. For all topics, emphasis is given to translational application of recent and current discoveries. In summary, the program integrates the most relevant and timely topics in basic and applied aspects of liver health and disease to promote scientific exchange, dissemination, education and collaboration and translation to patient care.
For more information, visit website.
FASEB-Federation of American Societies for Experimental Biology